<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Imcd N.v. — News on 6ix</title>
<link>https://6ix.com/company/imcd-nv-1</link>
<description>Latest news and press releases for Imcd N.v. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 04 Mar 2026 07:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/imcd-nv-1" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d549a5beedb30cb6f761ab.webp</url>
<title>Imcd N.v.</title>
<link>https://6ix.com/company/imcd-nv-1</link>
</image>
<item>
<title>IMCD nominates Andreas Igerl as CCO and member of the Management Board</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-nominates-andreas-igerl-as-cco-and-member-of-the-management-board-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-nominates-andreas-igerl-as-cco-and-member-of-the-management-board-1</guid>
<pubDate>Wed, 04 Mar 2026 07:00:00 GMT</pubDate>
<description>Rotterdam, the Netherlands (4 March 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, is pleased to announce that its Supervisory Board nominates Andreas Igerl to become Chief Commercial Officer (CCO) and member of the Management Board. Andreas Igerl, in his role as CCO, will strengthen the Management Board with his international experience and will further drive commercial excellence within IMCD. In ad</description>
</item>
<item>
<title>IMCD releases 2025 Annual Report</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-releases-2025-annual-report-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-releases-2025-annual-report-1</guid>
<pubDate>Wed, 04 Mar 2026 07:00:00 GMT</pubDate>
<description>Rotterdam, the Netherlands (4 March 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today releases its 2025 Annual Report. The report offers the Company’s stakeholders a comprehensive view of IMCD’s performance in 2025. The full annual report is available in the investor relations page of the Company’s website. Financial calendar:4 March 2026 Annual report 202530 April 2026 First three months 2026 res</description>
</item>
<item>
<title>IMCD nominates Ruud Joosten as Supervisory Board member</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-nominates-ruud-joosten-as-supervisory-board-member-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-nominates-ruud-joosten-as-supervisory-board-member-1</guid>
<pubDate>Wed, 04 Mar 2026 07:00:00 GMT</pubDate>
<description>Rotterdam, the Netherlands (4 March 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, is pleased to announce that its Supervisory Board nominates Ruud Joosten as member of the Supervisory Board. Ruud Joosten is the CEO of Royal BAM Group NV since 2020 and is a non-executive board member at Altana AG since 2024. He started his career at Sigma Coatings (currently PPG) in 1988. He joined AkzoNobel in 1996</description>
</item>
<item>
<title>IMCD to acquire Willows Ingredients to strengthen its food & nutrition offering throughout Ireland and the UK</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-to-acquire-willows-ingredients-to-strengthen-its-food-and-nutrition-offering-throughout-ireland-and-the-uk-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-to-acquire-willows-ingredients-to-strengthen-its-food-and-nutrition-offering-throughout-ireland-and-the-uk-1</guid>
<pubDate>Fri, 20 Feb 2026 07:00:00 GMT</pubDate>
<description>The acquisition will enhance IMCD’s capabilities in specialised health, sports and animal nutrition Rotterdam, the Netherlands (20 February 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces it has signed an agreement to acquire 100% of the shares in Willows Ingredients Group Limited (Willows Ingredients), a distributor of ingredients serving the food and nutrition sector with expertise i</description>
</item>
<item>
<title>IMCD reports EBITA of EUR 498 million in 2025</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-reports-ebita-of-eur-498-million-in-2025-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-reports-ebita-of-eur-498-million-in-2025-1</guid>
<pubDate>Wed, 18 Feb 2026 06:00:00 GMT</pubDate>
<description>Rotterdam, The Netherlands (18 February 2026) - IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces its full-year 2025 results. HIGHLIGHTS• Revenue at EUR 4,779 million (+5% on a constant currency basis)• Gross profit at EUR 1,194 million (+3% on a constant currency basis)• Operating EBITA at EUR 498 million (-3% on a constant currency basis)• Free cash flow up by 3% to EUR 465 million (2024: EUR</description>
</item>
<item>
<title>IMCD Full Year results 2025 webcast invitation</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-full-year-results-2025-webcast-invitation-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-full-year-results-2025-webcast-invitation-1</guid>
<pubDate>Wed, 21 Jan 2026 09:12:00 GMT</pubDate>
<description>Rotterdam, The Netherlands (21 January 2026) We are pleased to inform you that IMCD will publish its Full Year results 2025 on Wednesday 18 February 2026 at 07.00 am CET. Following the publication, Marcus Jordan (CEO) and Hans Kooijmans (CFO) will host an analyst conference call & webcast starting at 09.00 am CET. The presentation will be made available on the publication date at 7:00 am CET on our website under the Investor Relations section. A replay of the webcast will be uploaded to our webs</description>
</item>
<item>
<title>Floris Lagerwerf nominated future CFO of IMCD as of January 2027</title>
<link>https://6ix.com/company/imcd-nv-1/news/floris-lagerwerf-nominated-future-cfo-of-imcd-as-of-january-2027-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/floris-lagerwerf-nominated-future-cfo-of-imcd-as-of-january-2027-1</guid>
<pubDate>Fri, 12 Dec 2025 07:00:00 GMT</pubDate>
<description>Rotterdam, The Netherlands (12 December 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, is pleased to announce that its Supervisory Board nominates Floris Lagerwerf to become Chief Financial Officer (CFO) of IMCD as of January 2027. Floris will succeed Hans Kooijmans, who has decided to retire as per the end of December 2026. Floris started his career as external auditor in 2006, and he joined IMCD in</description>
</item>
<item>
<title>IMCD: Supervisory Board members nominated for reappointment</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-supervisory-board-members-nominated-for-reappointment-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-supervisory-board-members-nominated-for-reappointment-1</guid>
<pubDate>Fri, 12 Dec 2025 07:00:00 GMT</pubDate>
<description>Rotterdam, The Netherlands (12 December 2025) – “IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, announces that the Supervisory Board of IMCD nominates Mr. Janus Smalbraak for reappointment as member and Chair of the Supervisory Board at the next Annual General Meeting (AGM) in 2026. In addition to the nomination of Janus Smalbraak, the Supervisory Board nominates Mr. Stephan Nanninga for a third term of two</description>
</item>
<item>
<title>IMCD reports EBITA of EUR 394 million in the first nine months of 2025</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-reports-ebita-of-eur-394-million-in-the-first-nine-months-of-2025-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-reports-ebita-of-eur-394-million-in-the-first-nine-months-of-2025-1</guid>
<pubDate>Thu, 06 Nov 2025 06:00:00 GMT</pubDate>
<description>Rotterdam, The Netherlands (6 November 2025) - IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces its first nine months 2025 results. HIGHLIGHTS Gross profit up by 2% to EUR 927 million (+5% on a constant currency basis)Operating EBITA down by 2% to EUR 394 million (+1% on a constant currency basis)Free cash flow of EUR 284 million (first nine months 2024: EUR 299 million)Cash earnings per share</description>
</item>
<item>
<title>IMCD 2025 First Nine Months 2025 results webcast invitation</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-2025-first-nine-months-2025-results-webcast-invitation-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-2025-first-nine-months-2025-results-webcast-invitation-1</guid>
<pubDate>Wed, 22 Oct 2025 08:00:00 GMT</pubDate>
<description>Rotterdam, The Netherlands (22 October 2025) We are pleased to inform you that IMCD will publish its First Nine Months 2025 results on Thursday 6 November 2025 at 07.00 am CET. Following the publication, Marcus Jordan (CEO) and Hans Kooijmans (CFO) will host an analyst conference call & webcast starting at 09.00 am CET. The presentation will be made available on the publication date at 7:00 am CET on our website under the Investor Relations section. A replay of the webcast will be uploaded to ou</description>
</item>
<item>
<title>IMCD to acquire Dong Yang FT to strengthen position in beauty and personal care in South Korea</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-to-acquire-dong-yang-ft-to-strengthen-position-in-beauty-and-personal-care-in-south-korea-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-to-acquire-dong-yang-ft-to-strengthen-position-in-beauty-and-personal-care-in-south-korea-1</guid>
<pubDate>Thu, 16 Oct 2025 16:00:00 GMT</pubDate>
<description>Rotterdam, The Netherlands (16 October 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, has signed an agreement to acquire 100% of the shares in Dong Yang FT Corp. ("Dong Yang FT"). Founded in 2009 and based in Seoul, South Korea, Dong Yang FT is a distributor of high-quality cosmetic ingredients, working with cosmetic manufacturers across the beauty and personal care sector. With a team of 14 people a</description>
</item>
<item>
<title>IMCD celebrates 30 years of growth, partnership and innovation</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-celebrates-30-years-of-growth-partnership-and-innovation-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-celebrates-30-years-of-growth-partnership-and-innovation-1</guid>
<pubDate>Thu, 25 Sep 2025 06:00:00 GMT</pubDate>
<description>Rotterdam, The Netherlands (25 September 2025) – IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner and formulator of specialty chemicals and ingredients, is proud to celebrate its 30th anniversary. Founded in Rotterdam in 1995, IMCD has grown from a humble base in the Benelux and France into a global leader with more than 5,200 employees across 60+ countries, supported by 110 offices, 80 laboratories and 150 warehouses worldwide. Over three decades, IMCD has transformed dist</description>
</item>
<item>
<title>IMCD to acquire Tillmanns to further strengthen its presence in Italy</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-to-acquire-tillmanns-to-further-strengthen-its-presence-in-italy-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-to-acquire-tillmanns-to-further-strengthen-its-presence-in-italy-1</guid>
<pubDate>Wed, 27 Aug 2025 06:00:00 GMT</pubDate>
<description>Rotterdam, The Netherlands (27 August 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, has signed an agreement to acquire 100% of the shares in Tillmanns S.p.A. (“Tillmanns”). Founded in 1940 and headquartered in Milan, Italy, Tillmanns is a well-established distributor of specialty chemicals, acting as a key partner for global suppliers and a broad base of customers. With operations strongly anchored</description>
</item>
<item>
<title>IMCD receives upgraded ESG ratings from ISS ESG and Sustainalytics</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-receives-upgraded-esg-ratings-from-iss-esg-and-sustainalytics-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-receives-upgraded-esg-ratings-from-iss-esg-and-sustainalytics-1</guid>
<pubDate>Wed, 13 Aug 2025 06:00:00 GMT</pubDate>
<description>Improvements reflect continued progress on emissions, transparency and ESG risk management. Rotterdam, The Netherlands (13 August 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, has received improved ratings from two leading rating agencies: ISS ESG and Sustainalytics. These upgrades reflect the company’s ongoing progress across key environmental, social and governance (ESG) areas. The recognition fol</description>
</item>
<item>
<title>IMCD reports EBITA of EUR 275 million in the first half of 2025</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-reports-ebita-of-eur-275-million-in-the-first-half-of-2025-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-reports-ebita-of-eur-275-million-in-the-first-half-of-2025-1</guid>
<pubDate>Wed, 30 Jul 2025 05:00:00 GMT</pubDate>
<description>Rotterdam, The Netherlands (30 July 2025) - IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces its first half 2025 results. HIGHLIGHTS• Gross profit up by 5% to EUR 634 million (+7% on a constant currency basis)• Operating EBITA up by +2% to EUR 275 million (+4% on a constant currency basis)• Free cash flow of EUR 173 million (first half 2024: EUR 221 million)• Cash earnings per share at EUR 2.94</description>
</item>
<item>
<title>IMCD appoints Andreas Igerl to lead EMEA region and global Industrial Business Groups, and Narendra Varde to lead APAC region</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-appoints-andreas-igerl-to-lead-emea-region-and-global-industrial-business-groups-and-narendra-varde-to-lead-apac-region-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-appoints-andreas-igerl-to-lead-emea-region-and-global-industrial-business-groups-and-narendra-varde-to-lead-apac-region-1</guid>
<pubDate>Wed, 16 Jul 2025 06:00:00 GMT</pubDate>
<description>Rotterdam, The Netherlands (16 July 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, announces the appointment of Andreas Igerl as Regional President Europe, Middle East & Africa (EMEA) as of 1 September 2025, and as Leader of the global Industrial Business Groups, with effect progressively over the course of 2025. Narendra Varde is appointed as Regional President Asia-Pacific (APAC), succeeding Andrea</description>
</item>
<item>
<title>IMCD awarded EcoVadis Platinum medal</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-awarded-ecovadis-platinum-medal-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-awarded-ecovadis-platinum-medal-1</guid>
<pubDate>Wed, 02 Jul 2025 06:00:00 GMT</pubDate>
<description>Rotterdam, The Netherlands (02 July 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, announces it has been awarded the Platinum medal by EcoVadis. This recognition places IMCD in the top 1% of companies globally assessed by EcoVadis for sustainability in the last 12 months. IMCD achieved an overall score of 84 points. EcoVadis is a globally recognised provider of business sustainability ratings, evalua</description>
</item>
<item>
<title>IMCD acquires Apus Química to strengthen its offering to the advanced materials industry in Chile</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-acquires-apus-quimica-to-strengthen-its-offering-to-the-advanced-materials-industry-in-chile-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-acquires-apus-quimica-to-strengthen-its-offering-to-the-advanced-materials-industry-in-chile-1</guid>
<pubDate>Mon, 30 Jun 2025 06:00:00 GMT</pubDate>
<description>Rotterdam, The Netherlands (30 June 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, has announced the acquisition of 100% of the shares in Apus Química SpA (“Apus Quimica”). Founded in 2016 and headquartered in Santiago, Chile, Apus Quimica specialises in the distribution and development of performance chemicals for the rubber, plastics and chemical sectors. With four employees and two warehouses, Apu</description>
</item>
<item>
<title>IMCD acquires Trichem to accelerate its growth in the pharmaceutical markets in India</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-acquires-trichem-to-accelerate-its-growth-in-the-pharmaceutical-markets-in-india-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-acquires-trichem-to-accelerate-its-growth-in-the-pharmaceutical-markets-in-india-1</guid>
<pubDate>Thu, 26 Jun 2025 16:00:00 GMT</pubDate>
<description>Rotterdam, The Netherlands (26 June 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, has announced the acquisition of 100% of the shares in Trichem Healthcare Private Limited, Trichem Lifesciences Limited and Chemistry & Health FZ LLC. Founded in 1998 and headquartered in Mumbai, India, Trichem has built a strong reputation in the healthcare sector, supplying high-quality active pharmaceutical ingredie</description>
</item>
<item>
<title>IMCD to accelerate food & beverage growth in Iberia with strategic acquisition of Ferrer Alimentación</title>
<link>https://6ix.com/company/imcd-nv-1/news/imcd-to-accelerate-food-and-beverage-growth-in-iberia-with-strategic-acquisition-of-ferrer-alimentacion-1</link>
<guid isPermaLink="true">https://6ix.com/company/imcd-nv-1/news/imcd-to-accelerate-food-and-beverage-growth-in-iberia-with-strategic-acquisition-of-ferrer-alimentacion-1</guid>
<pubDate>Fri, 06 Jun 2025 06:00:00 GMT</pubDate>
<description>Rotterdam, The Netherlands (6 June 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, has signed an agreement to acquire 100% of the shares in Ferrer Alimentación, S.A. and Medir Ferrer Y Compañía, S.A. (jointly “Ferrer Alimentación”). Founded in 1955, Ferrer Alimentación is a leading distributor in Iberia of food and beverage ingredients. Ferrer Alimentación is well established and recognised for its st</description>
</item>
</channel>
</rss>